Tag: CardioCel®
Admedus sells its CardioCel and VascuCel patch business for $A36.2m
ASX-listed health technologies manufacturer Admedus has reached an agreement to sell its CardioCel and VascuCel patch business to US based LeMaitre Vascular Inc. for up to...
Admedus completes acquisition of WA manufacturing site for CardioCel
Admedus has announced that it has completed the purchase of an established manufacturing site from Genzyme Australia to facilitate increased production of its lead...
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
